OverviewSuggest Edit

    Mironid is a drug discovery company. It develops drug candidate molecules by modulating the activity of key cell-signaling proteins. Mironid's pipeline is aimed at developing treatments for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

    Latest Updates

    Employees (est.) (Feb 2020)11

    Mironid Financials and Metrics

    Summary Metrics

    Founding Date


    Mironid latest funding size

    $6.20 m

    Mironid investors

    Show all financial metrics

    Mironid Online and Social Media Presence

    Embed Graph

    Mironid Frequently Asked Questions

    • When was Mironid founded?

      Mironid was founded in 2015.

    • How many employees does Mironid have?

      Mironid has 11 employees.

    • Who are Mironid competitors?

      Competitors of Mironid include PEP-Therapy, Iproteos and Adaptate Biotherapeutics.